Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Stock Forecast

Stock Price Forecast

According to 19 professional analysts, the 12-month price target for Neurocrine Biosciences stock ranges from a low of $115 to a high of $203. The average analyst price target of $173.79 forecasts a 11.75% increase in the stock price over the next year.

Price Target: $173.79 (+11.75%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$115	$173.79	$179	$203
Change	-26.05%	+11.75%	+15.11%	+30.54%

Analyst Ratings

The average analyst rating for Neurocrine Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	10	10	9	10	10	11
Buy	10	8	7	7	7	7
Hold	2	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	22	19	17	18	18	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Phil Nadeau TD Cowen	TD Cowen	Strong Buy Maintains $175 → $200	Strong Buy	Maintains	$175 → $200	+28.61%	Dec 5, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $178 → $173	Buy	Maintains	$178 → $173	+11.25%	Nov 11, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $171 → $179	Buy	Maintains	$171 → $179	+15.11%	Nov 3, 2025
Danielle Brill Truist Securities	Truist Securities	Strong Buy Reiterates $165 → $172	Strong Buy	Reiterates	$165 → $172	+10.60%	Oct 30, 2025
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $160 → $164	Strong Buy	Maintains	$160 → $164	+5.46%	Oct 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.92B

Increased by 23.76%

from 2.36B

Revenue Next Year

3.44B

Increased by 18.01%

from 2.92B

EPS This Year

5.14

Increased by 56.20%

from 3.29

EPS Next Year

6.89

Increased by 34.01%

from 5.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.05B	1.13B	1.49B	1.89B	2.36B	2.92B	3.44B
Revenue Growth	32.71%	8.38%	31.34%	26.76%	24.81%	23.76%	18.01%
EPS	4.16	0.92	1.56	2.47	3.29	5.14	6.89
EPS Growth	966.67%	-77.89%	69.57%	58.33%	33.20%	56.20%	34.01%
Forward PE	-	-	-	-	-	30.26	22.58
No. Analysts	-	-	-	-	-	30	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	3.0B	3.8B
Avg	2.9B	3.4B
Low	2.8B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	28.6%	31.5%
Avg	23.8%	18.0%
Low	17.1%	4.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	5.82	9.45
Avg	5.14	6.89
Low	4.46	3.55

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	76.8%	83.9%
Avg	56.2%	34.0%
Low	35.5%	-31.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.